Cargando…
Real‐world assessment of the clinical impact of symptomatic infection with severe acute respiratory syndrome coronavirus (COVID‐19 disease) in patients with multiple myeloma receiving systemic anti‐cancer therapy
| Autores principales: | , , , , , , , , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
John Wiley and Sons Inc.
2020
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7280609/ https://www.ncbi.nlm.nih.gov/pubmed/32438482 http://dx.doi.org/10.1111/bjh.16874 |
| _version_ | 1783543769440714752 |
|---|---|
| author | Cook, Gordon John Ashcroft, A Pratt, Guy Popat, Rakesh Ramasamy, Karthik Kaiser, Martin Jenner, Matthew Henshaw, Sarah Hall, Rachel Sive, Jonathan Stern, Simon Streetly, Matthew Bygrave, Ceri Soutar, Richard Rabin, Neil Jackson, Graham H |
| author_facet | Cook, Gordon John Ashcroft, A Pratt, Guy Popat, Rakesh Ramasamy, Karthik Kaiser, Martin Jenner, Matthew Henshaw, Sarah Hall, Rachel Sive, Jonathan Stern, Simon Streetly, Matthew Bygrave, Ceri Soutar, Richard Rabin, Neil Jackson, Graham H |
| author_sort | Cook, Gordon |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-7280609 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2020 |
| publisher | John Wiley and Sons Inc. |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-72806092020-06-09 Real‐world assessment of the clinical impact of symptomatic infection with severe acute respiratory syndrome coronavirus (COVID‐19 disease) in patients with multiple myeloma receiving systemic anti‐cancer therapy Cook, Gordon John Ashcroft, A Pratt, Guy Popat, Rakesh Ramasamy, Karthik Kaiser, Martin Jenner, Matthew Henshaw, Sarah Hall, Rachel Sive, Jonathan Stern, Simon Streetly, Matthew Bygrave, Ceri Soutar, Richard Rabin, Neil Jackson, Graham H Br J Haematol Covid‐19 John Wiley and Sons Inc. 2020-06-10 2020-07 /pmc/articles/PMC7280609/ /pubmed/32438482 http://dx.doi.org/10.1111/bjh.16874 Text en © 2020 The Authors. British Journal of Haematology published by British Society for Haematology and John Wiley & Sons Ltd https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article under the terms of the http://creativecommons.org/licenses/by-nc-nd/4.0/ (https://creativecommons.org/licenses/by-nc-nd/4.0/) License, which permits use and distribution in any medium, provided the original work is properly cited, the use is non‐commercial and no modifications or adaptations are made. |
| spellingShingle | Covid‐19 Cook, Gordon John Ashcroft, A Pratt, Guy Popat, Rakesh Ramasamy, Karthik Kaiser, Martin Jenner, Matthew Henshaw, Sarah Hall, Rachel Sive, Jonathan Stern, Simon Streetly, Matthew Bygrave, Ceri Soutar, Richard Rabin, Neil Jackson, Graham H Real‐world assessment of the clinical impact of symptomatic infection with severe acute respiratory syndrome coronavirus (COVID‐19 disease) in patients with multiple myeloma receiving systemic anti‐cancer therapy |
| title | Real‐world assessment of the clinical impact of symptomatic infection with severe acute respiratory syndrome coronavirus (COVID‐19 disease) in patients with multiple myeloma receiving systemic anti‐cancer therapy |
| title_full | Real‐world assessment of the clinical impact of symptomatic infection with severe acute respiratory syndrome coronavirus (COVID‐19 disease) in patients with multiple myeloma receiving systemic anti‐cancer therapy |
| title_fullStr | Real‐world assessment of the clinical impact of symptomatic infection with severe acute respiratory syndrome coronavirus (COVID‐19 disease) in patients with multiple myeloma receiving systemic anti‐cancer therapy |
| title_full_unstemmed | Real‐world assessment of the clinical impact of symptomatic infection with severe acute respiratory syndrome coronavirus (COVID‐19 disease) in patients with multiple myeloma receiving systemic anti‐cancer therapy |
| title_short | Real‐world assessment of the clinical impact of symptomatic infection with severe acute respiratory syndrome coronavirus (COVID‐19 disease) in patients with multiple myeloma receiving systemic anti‐cancer therapy |
| title_sort | real‐world assessment of the clinical impact of symptomatic infection with severe acute respiratory syndrome coronavirus (covid‐19 disease) in patients with multiple myeloma receiving systemic anti‐cancer therapy |
| topic | Covid‐19 |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7280609/ https://www.ncbi.nlm.nih.gov/pubmed/32438482 http://dx.doi.org/10.1111/bjh.16874 |
| work_keys_str_mv | AT cookgordon realworldassessmentoftheclinicalimpactofsymptomaticinfectionwithsevereacuterespiratorysyndromecoronaviruscovid19diseaseinpatientswithmultiplemyelomareceivingsystemicanticancertherapy AT johnashcrofta realworldassessmentoftheclinicalimpactofsymptomaticinfectionwithsevereacuterespiratorysyndromecoronaviruscovid19diseaseinpatientswithmultiplemyelomareceivingsystemicanticancertherapy AT prattguy realworldassessmentoftheclinicalimpactofsymptomaticinfectionwithsevereacuterespiratorysyndromecoronaviruscovid19diseaseinpatientswithmultiplemyelomareceivingsystemicanticancertherapy AT popatrakesh realworldassessmentoftheclinicalimpactofsymptomaticinfectionwithsevereacuterespiratorysyndromecoronaviruscovid19diseaseinpatientswithmultiplemyelomareceivingsystemicanticancertherapy AT ramasamykarthik realworldassessmentoftheclinicalimpactofsymptomaticinfectionwithsevereacuterespiratorysyndromecoronaviruscovid19diseaseinpatientswithmultiplemyelomareceivingsystemicanticancertherapy AT kaisermartin realworldassessmentoftheclinicalimpactofsymptomaticinfectionwithsevereacuterespiratorysyndromecoronaviruscovid19diseaseinpatientswithmultiplemyelomareceivingsystemicanticancertherapy AT jennermatthew realworldassessmentoftheclinicalimpactofsymptomaticinfectionwithsevereacuterespiratorysyndromecoronaviruscovid19diseaseinpatientswithmultiplemyelomareceivingsystemicanticancertherapy AT henshawsarah realworldassessmentoftheclinicalimpactofsymptomaticinfectionwithsevereacuterespiratorysyndromecoronaviruscovid19diseaseinpatientswithmultiplemyelomareceivingsystemicanticancertherapy AT hallrachel realworldassessmentoftheclinicalimpactofsymptomaticinfectionwithsevereacuterespiratorysyndromecoronaviruscovid19diseaseinpatientswithmultiplemyelomareceivingsystemicanticancertherapy AT sivejonathan realworldassessmentoftheclinicalimpactofsymptomaticinfectionwithsevereacuterespiratorysyndromecoronaviruscovid19diseaseinpatientswithmultiplemyelomareceivingsystemicanticancertherapy AT sternsimon realworldassessmentoftheclinicalimpactofsymptomaticinfectionwithsevereacuterespiratorysyndromecoronaviruscovid19diseaseinpatientswithmultiplemyelomareceivingsystemicanticancertherapy AT streetlymatthew realworldassessmentoftheclinicalimpactofsymptomaticinfectionwithsevereacuterespiratorysyndromecoronaviruscovid19diseaseinpatientswithmultiplemyelomareceivingsystemicanticancertherapy AT bygraveceri realworldassessmentoftheclinicalimpactofsymptomaticinfectionwithsevereacuterespiratorysyndromecoronaviruscovid19diseaseinpatientswithmultiplemyelomareceivingsystemicanticancertherapy AT soutarrichard realworldassessmentoftheclinicalimpactofsymptomaticinfectionwithsevereacuterespiratorysyndromecoronaviruscovid19diseaseinpatientswithmultiplemyelomareceivingsystemicanticancertherapy AT rabinneil realworldassessmentoftheclinicalimpactofsymptomaticinfectionwithsevereacuterespiratorysyndromecoronaviruscovid19diseaseinpatientswithmultiplemyelomareceivingsystemicanticancertherapy AT jacksongrahamh realworldassessmentoftheclinicalimpactofsymptomaticinfectionwithsevereacuterespiratorysyndromecoronaviruscovid19diseaseinpatientswithmultiplemyelomareceivingsystemicanticancertherapy AT realworldassessmentoftheclinicalimpactofsymptomaticinfectionwithsevereacuterespiratorysyndromecoronaviruscovid19diseaseinpatientswithmultiplemyelomareceivingsystemicanticancertherapy |